Phenylpyridine-2-ylguanidines and rigid mimetics as novel inhibitors of TNFα overproduction: Beneficial action in models of neuropathic pain and of acute lung inflammation

Eur J Med Chem. 2018 Mar 10:147:163-182. doi: 10.1016/j.ejmech.2018.01.049. Epub 2018 Jan 31.

Abstract

4-phenylpyridin-2-yl-guanidine (5b): a new inhibitor of the overproduction of pro-inflammatory cytokines (TNFα and Il1β) was identified from a high-throughput screening of a chemical library on human peripheral blood mononuclear cells (PBMCs) after LPS stimulation. Derivatives, homologues and rigid mimetics of 5b were designed and synthesized, and their cytotoxicity and ability to inhibit TNFα overproduction were evaluated. Among them, compound 5b and its mimetic 12 (2-aminodihydroquinazoline) showed similar inhibitory activities, and were evaluated in vivo in models of lung inflammation and neuropathic pain in mice. In particular, compound 12 proved to be active (5 mg/kg, ip) in both models.

Keywords: Inflammation; Neuropathic pain; Phenotypic screening; Pyridine-2-yl guanidine; TNFα inhibitor.

Publication types

  • Review

MeSH terms

  • Acute Lung Injury / drug therapy*
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / chemical synthesis
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Guanidines / chemical synthesis
  • Guanidines / chemistry
  • Guanidines / pharmacology*
  • Humans
  • Inflammation / drug therapy*
  • Models, Biological*
  • Neuralgia / drug therapy*
  • Neuralgia / metabolism
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Guanidines
  • Tumor Necrosis Factor-alpha